GTEx Breast 20-29 vs 50-59 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx Breast 20-29 vs 50-59 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx Breast 20-29 vs 50-59 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx Breast 20-29 vs 50-59 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx Breast 20-29 vs 50-59 Down.

Results found

Linked to

 

Label

Description

 

Gene

PAX8 antisense RNA 1

Gene

cancer susceptibility 8

Gene

olfactory receptor family 2 subfamily A member 20 pseudogene

Gene

AZGP1 pseudogene 1

Gene

DPP10 antisense RNA 1

Gene

TIAM1 antisense RNA 1

Gene

long intergenic non-protein coding RNA 1235

Gene

long intergenic non-protein coding RNA 2714

Gene

ankyrin repeat domain 20 family member A8, pseudogene

Gene

MIR200C and MIR141 host gene

  • Gene

    PAX8 antisense RNA 1


  • Gene

    cancer susceptibility 8


  • Gene

    olfactory receptor family 2 subfamily A member 20 pseudogene


  • Gene

    AZGP1 pseudogene 1


  • Gene

    DPP10 antisense RNA 1


  • Gene

    TIAM1 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 1235


  • Gene

    long intergenic non-protein coding RNA 2714


  • Gene

    ankyrin repeat domain 20 family member A8, pseudogene


  • Gene

    MIR200C and MIR141 host gene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.